For Immediate Release

October 31, 2014

Sumitomo Chemical Reports
Consolidated Financial Results
For the Half-Year Ended September 30, 2014
The Sumitomo Chemical Group’s sales for the half-year ended September 30, 2014
were ¥1,128.4 billion, an increase of ¥77.6 billion compared with the same period of
the previous fiscal year. Operating income came to ¥36.2 billion, showing ayear-on-year decrease. The Group recorded ordinary income of ¥52.8 billion and net
income of ¥22.6 billion, both representing year-on-year increases due to animprovement in equity in earnings of affiliates.
Sumitomo Chemical decided to pay an interim dividend of ¥6 per share.
The Sumitomo Chemical Group’s financial results by business segment for thehalf-year were as follows.
Basic Chemicals
Sales of methyl methacrylate grew due to an increase in shipments and higher
market prices. Sales of aluminum also rose due to higher market prices. Market
prices remained low for raw materials for synthetic fibers, however, and shipments ofthese products decreased. As a result, the segment’s sales increased by ¥18.0 billion
from the same period of the previous fiscal year, to ¥155.0 billion. Operating income
improved by ¥0.9 billion, to a loss of ¥3.9 billion.
Petrochemicals & Plastics
Shipments of synthetic resins from overseas subsidiaries increased. Market prices of
petrochemical products and synthetic resins also increased because of higher
feedstock prices. As a result, the segment’s sales grew by ¥37.7 billion from the same
period of the previous fiscal year, to ¥406.7 billion, and operating income rose by ¥0.6billion, to ¥4.5 billion.
IT-related Chemicals
Shipments of polarizing film used in liquid crystal displays (LCDs) increased due togrowth in demand, while selling prices of polarizing film declined. Although selling
prices of touchscreen panels declined, shipments grew because of increased
production capacity. As a result, the segment’s sales increased by ¥12.9 billion
compared with the same period of the previous fiscal year, to ¥194.7 billion.
Operating income decreased by ¥7.2 billion, to ¥14.5 billion, as it was adversely
affected by lower selling prices.
Health & Crop Sciences
Shipments of the feed additive methionine increased and market prices of methionine
are gradually recovering, though still lower than year-earlier levels. Shipments of thelong-lasting insecticidal mosquito net, Olyset® Net, also increased. On the otherhand, shipments of crop protection chemicals decreased in Japan and abroad due tothe effects of the consumption tax increase in Japan and unseasonable weather inSouth America. As a result, the segment’s sales increased by ¥10.0 billion comparedwith the same period of the previous fiscal year, to ¥149.5 billion. Operating income
decreased by ¥0.2 billion, to ¥11.4 billion.

Pharmaceuticals
In North America, shipments of Lunesta® (sedative hypnotic) decreased sharply asmarketing exclusivity ended. Shipments of Latuda® (atypical antipsychotic), however,expanded at a pace faster than expected. In Japan, overall sales decreased due to theimpacts of Japanese National Health Insurance drug price revisions and competition
from generic drugs. As a result, the segment’s sales declined by ¥2.8 billion
compared with the same period of the previous fiscal year, to ¥194.4 billion, andoperating income decreased by ¥5.2 billion, to ¥15.4 billion.
OthersIn addition to the above five segments, the Sumitomo Chemical Group engages insupplying electrical power and steam, providing services for the design, engineering,and construction management of chemical plants, providing transport andwarehousing, and conducting materials and environmental analysis. The segment’s
sales increased by ¥1.8 billion compared with the same period of the previous fiscalyear, to ¥28.2 billion. Operating income decreased by ¥0.7 billion, to ¥2.7 billion.

Summary of Consolidated Results(1) Results of Operations:Net sales
Operating income
Ordinary income
Income before income taxesand minority interests
Net income

Net income per 1,000 shares
Dividends per 1,000 shares:
Interim dividends

Comprehensive income(2) Financial Position:
Total assets
Total net asset(3) Cash Flows:

Cash flows from operating activities
Cash flows from investing activities
Cash flows from financing activities
Cash and cash equivalents at end of period(4) Results of Operations byBusiness Segment:
Net sales
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersOperating income (loss)
Basic Chemicals
Petrochemicals & Plastics
IT-related Chemicals
Health & Crop Sciences
Pharmaceuticals
OthersAdjustments

6 Months ended
September 30，2014
Yen (Millions)
USD (Thousands)*
1,128,417
10,309,886
36,177
330,534
52,835
482,732

6 Months ended
September 30，2013
Yen (Millions)
1,050,806
46,332
44,25052,437
22,588479,095
206,377

38,256
12,452

Yen
13,820

USD*
126

Yen
7,618

6,000

55

6,000

Yen (Millions)
62,077

USD (Thousands)*
567,172

Yen (Millions)
75,665

As of September 30, 2014
Yen (Millions)
USD (Thousands)*
2,868,807
26,211,119
981,579
8,968,287

As of March 31, 2014
Yen (Millions)
2,788,507
934,506

6 Months ended
September 30，2014
Yen (Millions)
USD (Thousands)*
14,028128,168(27,896)(254,874)
49,734454,399
174,652
1,595,724

6 Months ended
September 30，2013
Yen (Millions)
100,840(79,988)(4,622)
143,158

6 Months ended
September 30，2014
Yen (Millions)
USD (Thousands)*

6 Months ended
September 30，2013
Yen (Millions)

154,955
406,656
194,680
149,503
194,411
28,212
1,128,417

1,415,761
3,715,450
1,778,712
1,365,948
1,776,254
257,761
10,309,886

136,932
368,914
181,792
139,502
197,231
26,435
1,050,806(3,913)
4,496
14,494
11,413
15,4392,695(8,447)36,177(35,751)
41,078132,426
104,276
141,060
24,623(77,178)
330,534(4,796)
3,855
21,705
11,574
20,6303,416(10,052)
46,332(Note)*:U.S. dollar amounts are translated from yen, for convenience only, at the rate of¥109.45= $1 prevailing on September 30, 2014.